Gastrointestinal Behcet’s-like disease with myelodysplastic neoplasms with trisomy 8: a French case series and literature review

References

• International Team for the Revision of the International Criteria for Behçet’s Disease (ITR-ICBD). The International Criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol JEADV. 2014;28:338–347.
   PubMed Web of Science ®Google Scholar
• Mekinian A, Grignano E, Braun T, et al. Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study. Rheumatol Oxf Engl. 2016;55:291–300.
   PubMed Web of Science ®Google Scholar
• Montoro J, Gallur L, Merchán B, et al. Autoimmune disorders are common in myelodysplastic syndrome patients and confer an adverse impact on outcomes. Ann Hematol. 2018;97:1349–1356.
   PubMed Web of Science ®Google Scholar
• Fozza C. The burden of autoimmunity in myelodysplastic syndromes. Hematol Oncol. 2018;36:15–23.
   PubMed Web of Science ®Google Scholar
• Ohno E, Ohtsuka E, Watanabe K, et al. Behçet’s disease associated with myelodysplastic syndromes: a case report and a review of the literature. Cancer. 1997;79:262–268.
   PubMed Web of Science ®Google Scholar
• Kawano S, Hiraoka S, Okada H, et al. Clinical features of intestinal Behçet’s disease associated with myelodysplastic syndrome and trisomy 8. Acta Med Okayama. 2015;69:365–369.
   PubMed Web of Science ®Google Scholar
• Takizawa Y, Setoguchi K, Kobayashi T, et al. Severe gastrointestinal disease development coinciding with the progression of myelodysplastic syndrome after a long-term mild course of Behcet’s disease. Int J Rheum Dis. 2017;20:1856–1859.
   PubMed Web of Science ®Google Scholar
• Della Rossa A, Tavoni A, Tognetti A, et al. Behçet’s disease with gastrointestinal involvement associated with myelodysplasia in a patient with congenital panhypopituitarism. Clin Rheumatol. 1998;17:515–517.
   PubMed Web of Science ®Google Scholar
• Chen Y, Shen Y, Ma H-F, et al. Infliximab associated with life-threatening lung infection in a patient with Behcet disease with intestinal and hematopoietic system involvement: a case report. Medicine (Baltimore). 2017;96:e9202.
   PubMed Web of Science ®Google Scholar
• Yano K, Eguchi K, Migita K, et al. Behcet's disease complicated with myelodysplastic syndrome: a report of two cases and review of the literature. Clin Rheumatol. 1996;15:91–93.
   PubMed Web of Science ®Google Scholar
• Endo M, Sekikawa A, Tsumura T, et al. A case of myelodysplastic syndrome with intestinal Behçet's disease-like symptoms treated by prednisolone and azacitidine. Am J Case Rep. 2015;16:827–831.
   PubMed Web of Science ®Google Scholar
• Kimura M, Tsuji Y, Iwai M, et al. Usefulness of adalimumab for treating a case of intestinal Behçet's disease with trisomy 8 myelodysplastic syndrome. Intest Res. 2015;13:166–169.
   PubMed Web of Science ®Google Scholar
• Mantzourani MG, Chantziara K, Thanopoulou I, et al. Coexistence of Behcet's disease and chronic myelomonocyte leukemia with trisomy 8: a case report and review of the literature. Clin Exp Rheumatol. 2009;27:S85–S87.
   PubMed Web of Science ®Google Scholar
• Oh EJ, Yoon JS, Park YJ, et al. Behcet's disease associated with myelodysplastic syndrome: a case report. J Korean Med Sci. 1999;14:685–687.
   PubMed Web of Science ®Google Scholar
• Fine LA, Hoffman LD, Hoffman MD. Aphthous ulcerations associated with trisomy 8-positive myelodysplastic syndrome. J Am Acad Dermatol. 2007;57:S38–S41.
   PubMed Web of Science ®Google Scholar
• Kawabata H, Sawaki T, Kawanami T, et al. Myelodysplastic syndrome complicated with inflammatory intestinal ulcers: significance of trisomy 8. Intern Med. 2006;45:1309–1314.
   PubMed Web of Science ®Google Scholar
• Thachil JV, Salim R, Field A, et al. Myelodysplastic syndrome with trisomy 8 associated with Behçet syndrome: an immunologic link to a karyotypic abnormality. Pediatr Blood Cancer. 2008;50:649–651.
   PubMed Web of Science ®Google Scholar
• Koguchi-Yoshioka H, Inokuma D, Kanda M, et al. Behçet's disease-like symptoms associated with myelodysplastic syndrome with trisomy 8: a case report and review of the literature. Acta Derm Venereol. 2014;94:355–356.
   PubMed Web of Science ®Google Scholar
• Toyonaga T, Nakase H, Matsuura M, et al. Refractoriness of intestinal Behçet’s disease with myelodysplastic syndrome involving trisomy 8 to medical therapies - our case experience and review of the literature. Digestion. 2013;88:217–221.
   PubMed Web of Science ®Google Scholar
• Tanaka H, Shimizu N, Tougasaki E, et al. Successful treatment by azacitidine therapy of intestinal Behçet’s disease associated with myelodysplastic syndrome. Int J Hematol. 2013;97:520–524.
   PubMed Web of Science ®Google Scholar
• Chen H-C, Chiu Y-M. Large-vessel thrombosis in intestinal Behçet’s disease complicated with myelodysplastic syndrome and trisomy 8. World J Gastroenterol. 2012;18:1137–1140.
   PubMed Web of Science ®Google Scholar
• Shigemura T, Agematsu K, Yamazaki T, et al. A case of Behcet’s disease associated with myelodysplastic syndrome involving trisomy 8 and a gain-of-function mutation in SHP-2. Rheumatol Oxf Engl. 2011;50:1342–1344.
   PubMed Web of Science ®Google Scholar
• Lin Y-C, Liang T-H, Chang H-N, et al. Behçet disease associated with myelodysplastic syndrome. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis. 2008;14:169–174.
   Google Scholar
• Hasegawa H, Iwamasa K, Hatta N, et al. Behçet’s disease associated with myelodysplastic syndrome with elevated levels of inflammatory cytokines. Mod Rheumatol. 2003;13:350–355.
   PubMedGoogle Scholar
• Adachi Y, Tsutsumi A, Murata H, et al. Behçet’s disease accompanied by myelodysplastic syndrome with trisomy 8: two case reports and a review of 15 Japanese cases. Mod Rheumatol. 2003;13:90–94.
   PubMedGoogle Scholar
• Becker K, Fitzgerald O, Green AJ, et al. Constitutional trisomy 8 and Behçet syndrome. Am J Med Genet A. 2009;149A:982–986.
   PubMed Web of Science ®Google Scholar
• Kimura S, Kuroda J, Akaogi T, et al. Trisomy 8 involved in myelodysplastic syndromes as a risk factor for intestinal ulcers and thrombosis-Behçet's syndrome. Leuk Lymphoma. 2001;42:115–121.
   PubMed Web of Science ®Google Scholar
• de Hollanda A, Beucher A, Henrion D, et al. Systemic and immune manifestations in myelodysplasia: a multicenter retrospective study. Arthritis Care Res (Hoboken). 2011;63:1188–1194.
   PubMed Web of Science ®Google Scholar